Indication
In adult women of reproductive age for symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
Medicine details
- Medicine name:
- relugolix / estradiol / norethisterone acetate (Ryeqo)
- SMC ID:
- SMC2666
- Pharmaceutical company
- Gedeon Richter UK Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 03 June 2024